Mandate

Vinge advises Investor Growth Capital on the investment in Memira Holding AB

October 02, 2007

Vinge advises Investor Growth Capital in connection with the investment in Memira Holding AB, a Scandinavian laser eye surgery chain. Memira’s surgeries treat short and long sightedness as well as astigmatism, which is a common refractive error. The investment in the company will make Investor Growth Capital the owner of 40 per cent of the shares.

Investor Growth Capital is represented by partner Johan Winnerblad assisted by associates Johan Larsson, Tom Zachrisson and Theresa Kovac.

Related

Vinge advises parts of the consortium in connection with the public takeover offer for Cint

The public takeover offer was announced by a consortium consisting of Triton Fund 6, Bolero, Patrick Comer and Brett Schnittlich. The offer values all shares in Cint at approximately SEK 1,989 million. The shares in Cint are listed on Nasdaq Stockholm, Mid Cap.
April 27, 2026

Nordea and SEB enters into a SEK 2,000,000,000 credit facility agreement

On 22 April 2026, Nordea and SEB entered into a credit facility agreement in the aggregate amount of SEK 2,000,000,000 (with an accordion option for an additional SEK 400,000,000) with Humble Group AB (publ).
April 27, 2026

Vinge has advised Northmill in connection with its inaugural issuance of primary capital instruments (AT1)

Vinge has advised Northmill Group AB in connection with its issuance of SEK 275 million primary capital instruments (so called “AT1 bonds”) with a floating rate interest of 3-month STIBOR + 690 basis points. The AT1 bonds are perpetual with a first call option after five years and are intended to be admitted to trading on Nasdaq Transfer Market and, subsequently, on Nasdaq Stockholm.
April 27, 2026